Renal Transplantation Decreases Osteoprotegerin Levels

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2317-2318

  Bargnoux, A S ^a   Dupuy, A M ^a   Garrigue, V ^a   Deleuze, S ^a   Cristol, J P ^a   Mourad, G ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; OSTEOPROTEGERIN;

ADULT; ARTERY CALCIFICATION; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; KIDNEY TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; CALCINOSIS; CREATININE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOPROTEGERIN; TREATMENT OUTCOME;

EID: 33846070129     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.126     Document Type: Article

References (10)

1. Magee C.C., and Pascual M. Update in renal transplantation. Arch Intern Med 164 (2004) 1373
2. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154
3. Tintut Y., and Demer L.L. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 12 (2001) 555
4. Nitta K., Akiba T., Uchida K., et al. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19 (2004) 1886
5. Morena M., Terrier N., Jaussent I., et al. Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol 17 (2006) 262
6. Kazama J. Osteoprotegerin and bone mineral metabolism in renal failure. Curr Opin Nephrol Hypertens 13 (2004) 411
7. Moe S., Reslerova M., Ketteler M., et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease. Kidney Intern 67 (2005) 2295
8. Sato T., Tominaga Y., Iwasaki Y., et al. Osteoprotegerin level before and after renal transplantation. Am J Kidney Dis 38 suppl 1 (2001) S175
9. Sasaki N., Kusano E., Ando Y., et al. Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis. Nephro Dial Transplant 16 (2001) 479
10. Hofbauer L., Shui C., Riggs B., et al. Effects of immunosuppressants on receptor activator of NF-κB Ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 280 (2001) 334